Inden man anvender et radioaktivt lægemiddel hos en kvinde, der ammer, bør man overveje, om undersøgelsen kan vente, til kvinden er holdt op med at amme.
Before administering a radioactive medicinal product to a mother who is breast feeding, consideration should be given to whether the investigation could be reasonably delayed until the mother has ceased breastfeeding.